UnitedHealthcare
Tegsedi (inotersen)
Hormones : Hormones
  • Prior Authorization: Familial Amyloid Polyneuropathy (FAP):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Familial Amyloid Polyneuropathy (FAP):
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Neurologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Neuropathy Impairment Score: 1 of Baseline FAP Stage 1 or 2;Baseline polyneuropathy disability (PND) score <= IIIb;Neuropathy Impairment Score =>10 and <=130
    Diagnosis Types: hATTR Amyloidosis with Polyneuropathy
    Concomitant Therapy Restrictions: 1 of Patisiran (Onpattro);Vyndamax;Vyndaqel
    Required Documentation: Documentation of a pathogenic ttR mutation
    Specialist required details: Specialist Consultation